Member Info for Timster

Standard operation to install the BOP at this point.

:)

Or leave a short open....

https://avacta.wistia.com/medias/kv40kul5b2
https://avacta.com/investors/documents-presentations/

Spoiler alert, ava6000 is awesome....

Very well explained, great stuff, is it us?

https://tinyurl.com/4dnmsvaj

Nice bit of analysis
https://www.linkedin.com/posts/paul-hill-a5994116_avct-avct-activity-6919903964213751808-MfRp?utm_source=linkedin_share&utm_medium=android_app

I think the importance of this deal is more about it's potential to be the first affimer to enter human trials and be tested in Humans.

Unless someone ate an Affidx test that's not happened to date and will be a massive boost to affimers.

What you saying then? There are still 2 million odd shares that need buying back to close out?

"A very similar analogue to valcade" is what he says yep.

Was just listening to the presentation and noticed a distinction in the next prodrug. Ava6k delivers an unaltered version of Doxorubicin. But the next drug AVA3996 uses an altered version of velcade.

Does this mean that it would go through different trials and approvals and be treated as a new drug?

Just relistened to the results, AS says Q2 into Q3 so I'd say definitely a minimum of July is his mid year

That Emma Lou twitter explanation is really good, well worth a read

Haha awesome a guessing game as to when mid year is....

Always going to happen, much like a meeting the poster was built up to be something it isn't.

The most important ava6k news is that it is in trials and dose escalation, and is providing extremely consistent data.

AS did say he would do a presentation to explain it to the non scientific plebs, hopefully will be on the website soon.

Correct, it's the preclinical data and the compelling case as to why it moved to human trials

Don't want to be a party pooper but the poster presentation is preclinical data they will not be able to discuss the trials, other than what we have been told with DE.
So not sure why people are expecting a 20% rise? Confused......

Trial data however is transformational but that's mid year.

I've never been, but looking at the poster stands on twitter I would be amazed if avacta would get anyone to Sign an NDA before talking to them.

It's just an informal chat about the preclinical data that we already know about.
But as AS said he'll also present the poster in layman terms for us to understand.

Sorry PL it's the covid, I do apologise....

He's got some left after inking all those lft contracts pl75